TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch

Key Takeaways TMO enrolled the first patient in its global PPD CorEvitas Alzheimer's Disease Registry. TMO registry collects longitudinal, clinician-reported real-world data on therapy safety and effectiveness. TMO's registry monitors MRI brain changes, plaque clearance and other safety events in real-world care. Thermo Fisher Scientific Inc. (TMO) recently announced the enrollment of the first patient in its new PPD CorEvitas Alzheimer’s Disease Registry. The registry is designed as an international, multi ...